China
· Delayed Price · Currency is CNY Eyebright Medical Technology (Beijing) Statistics
Total Valuation
Eyebright Medical Technology (Beijing) has a market cap or net worth of CNY 17.48 billion. The enterprise value is 17.85 billion.
| Market Cap | 17.48B |
| Enterprise Value | 17.85B |
Important Dates
The next estimated earnings date is Friday, April 18, 2025.
| Earnings Date | Apr 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Eyebright Medical Technology (Beijing) has 189.54 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 189.54M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | -0.19% |
| Owned by Insiders (%) | 21.52% |
| Owned by Institutions (%) | 37.78% |
| Float | 123.16M |
Valuation Ratios
The trailing PE ratio is 47.32 and the forward PE ratio is 30.23.
| PE Ratio | 47.32 |
| Forward PE | 30.23 |
| PS Ratio | 12.83 |
| PB Ratio | 7.50 |
| P/TBV Ratio | 8.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.93, with an EV/FCF ratio of -103.13.
| EV / Earnings | 48.29 |
| EV / Sales | 13.14 |
| EV / EBITDA | 34.93 |
| EV / EBIT | 43.32 |
| EV / FCF | -103.13 |
Financial Position
The company has a current ratio of 4.76, with a Debt / Equity ratio of 0.25.
| Current Ratio | 4.76 |
| Quick Ratio | 3.47 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 1.23 |
| Debt / FCF | -3.63 |
| Interest Coverage | 20.01 |
Financial Efficiency
Return on equity (ROE) is 14.76% and return on invested capital (ROIC) is 9.38%.
| Return on Equity (ROE) | 14.76% |
| Return on Assets (ROA) | 8.72% |
| Return on Capital (ROIC) | 9.38% |
| Revenue Per Employee | 654,940 |
| Profits Per Employee | 178,206 |
| Employee Count | 2,074 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 2.32 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.54% in the last 52 weeks. The beta is 0.51, so Eyebright Medical Technology (Beijing)'s price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -15.54% |
| 50-Day Moving Average | 92.62 |
| 200-Day Moving Average | 81.33 |
| Relative Strength Index (RSI) | 49.10 |
| Average Volume (20 Days) | 2,642,562 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Eyebright Medical Technology (Beijing) had revenue of CNY 1.36 billion and earned 369.60 million in profits. Earnings per share was 1.95.
| Revenue | 1.36B |
| Gross Profit | 906.70M |
| Operating Income | 412.00M |
| Pretax Income | 412.27M |
| Net Income | 369.60M |
| EBITDA | 506.62M |
| EBIT | 412.00M |
| Earnings Per Share (EPS) | 1.95 |
Balance Sheet
The company has 469.25 million in cash and 627.69 million in debt, giving a net cash position of -158.44 million or -0.84 per share.
| Cash & Cash Equivalents | 469.25M |
| Total Debt | 627.69M |
| Net Cash | -158.44M |
| Net Cash Per Share | -0.84 |
| Equity (Book Value) | 2.54B |
| Book Value Per Share | 12.29 |
| Working Capital | 931.25M |
Cash Flow
In the last 12 months, operating cash flow was 298.91 million and capital expenditures -471.98 million, giving a free cash flow of -173.07 million.
| Operating Cash Flow | 298.91M |
| Capital Expenditures | -471.98M |
| Free Cash Flow | -173.07M |
| FCF Per Share | -0.91 |
Margins
Gross margin is 66.75%, with operating and profit margins of 30.33% and 27.21%.
| Gross Margin | 66.75% |
| Operating Margin | 30.33% |
| Pretax Margin | 30.35% |
| Profit Margin | 27.21% |
| EBITDA Margin | 37.30% |
| EBIT Margin | 30.33% |
| FCF Margin | -12.74% |
Dividends & Yields
This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 0.30%.
| Dividend Per Share | 0.27 |
| Dividend Yield | 0.30% |
| Dividend Growth (YoY) | 72.94% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 18.75% |
| Buyback Yield | -0.02% |
| Shareholder Yield | 0.28% |
| Earnings Yield | 2.11% |
| FCF Yield | -0.99% |
Stock Splits
The last stock split was on June 5, 2024. It was a forward split with a ratio of 1.8000180002.
| Last Split Date | Jun 5, 2024 |
| Split Type | Forward |
| Split Ratio | 1.8000180002 |
Scores
Eyebright Medical Technology (Beijing) has an Altman Z-Score of 12.58.
| Altman Z-Score | 12.58 |
| Piotroski F-Score | n/a |